PROTEIN PATHWAY BIOMARKER SIGNATURE ASSOCIATED WITH SUPERIMPOSED NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C

被引:0
|
作者
Stepanova, M. [1 ,2 ]
Limongi, D. [3 ]
Afendy, A. [1 ,2 ]
Pierobon, M. [3 ]
Younossi, I. [2 ]
Gramlich, T. [4 ]
Liotta, L. [3 ]
Petricoin, E. [3 ]
Younossi, Z. [1 ,2 ]
机构
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
[3] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA
[4] AmeriPath, Cleveland, OH USA
关键词
D O I
10.1016/S0168-8278(10)60384-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S157 / S157
页数:1
相关论文
共 50 条
  • [1] Non-alcoholic steatohepatitis (NASH) and chronic hepatitis C
    Perez-Carreras, M
    Castellano, G
    Rivas, E
    Colina, F
    Alvarez, V
    Tomas, E
    Fuertes, A
    Solis-Herruzo, JA
    JOURNAL OF HEPATOLOGY, 2002, 36 : 150 - 151
  • [2] Non-alcoholic steatohepatitis (NASH) in patients with chronic hepatitis
    Perez-Carreras, M
    Castellano, G
    Rivas, E
    Colina, F
    Alvarez, V
    Tomas, E
    Fuertes, A
    Solis-Herruzo, JA
    HEPATOLOGY, 2002, 36 (04) : 726A - 726A
  • [3] METABOLOMICS PROFILE OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS
    Younossi, Zobair M.
    Karrar, Azza
    Stepanova, Maria
    Lam, Brian P.
    Felix, Sean
    Jeffers, Thomas
    Hellings, Samuel
    Brown, Elizabeth
    Thompson, John
    Onorato, Joelle
    Reily, Michael
    Warrack, Bethanne
    Luo, Yi
    Zhelnin, Leonid
    Charles, Edgar D.
    Mukherjee, Sumanta
    Zhao, Lei
    Gordon, David
    Nader, Fatema
    Goodman, Zachary D.
    HEPATOLOGY, 2019, 70 : 1035A - 1036A
  • [4] Interaction of steatosis and non-alcoholic steatohepatitis (NASH) with chronic hepatitis C
    Younossi, ZM
    McCullough, AJ
    Ong, JP
    Barnes, DS
    Post, A
    Mullen, KD
    Carey, W
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, AS
    Ferguson, R
    GASTROENTEROLOGY, 2003, 124 (04) : A745 - A745
  • [5] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
    Younossi, Zobair M.
    Page, Sandra
    Rafiq, Nila
    Birerdinc, Aybike
    Stepanova, Maria
    Hossain, Noreen
    Afendy, Arian
    Younoszai, Zahra
    Goodman, Zachary
    Baranova, Ancha
    OBESITY SURGERY, 2011, 21 (04) : 431 - 439
  • [6] Factors associated with the presence of non-alcoholic steatohepatitis (NASH) lesions in patients with hepatitis C
    Solis-Herruzo, JA
    Perez-Carreras, M
    Garfia, C
    Fernandez-Vazquez, I
    Bernardos, E
    Rivas, E
    Colina, F
    JOURNAL OF HEPATOLOGY, 2004, 40 : 176 - 176
  • [7] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
    Zobair M. Younossi
    Sandra Page
    Nila Rafiq
    Aybike Birerdinc
    Maria Stepanova
    Noreen Hossain
    Arian Afendy
    Zahra Younoszai
    Zachary Goodman
    Ancha Baranova
    Obesity Surgery, 2011, 21 : 431 - 439
  • [8] Non-Alcoholic Steatohepatitis (NASH) Influences the Disease Progression of Chronic Hepatitis C
    Matsumoto, T.
    Ogura, K.
    MODERN PATHOLOGY, 2012, 25 : 419A - 419A
  • [9] Non-Alcoholic Steatohepatitis (NASH) Influences the Disease Progression of Chronic Hepatitis C
    Matsumoto, T.
    Ogura, K.
    LABORATORY INVESTIGATION, 2012, 92 : 419A - 419A
  • [10] Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study
    Aller, Rocio
    Calleja, Jose Luis
    Crespo, Javier
    Romero-Gomez, Manuel
    Turnes, Juan
    Benmarzouk-Hidalgo, Omar J.
    Subiran, Rafael
    Gil, Alicia
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (04): : 337 - 346